Archive for March, 2002

h1

11248656

March 29, 2002

Pharmaceutical Spending Continues Steady Increase
“For the fourth straight year, prescription drug spending rose more than 17 percent in 2001, driven in large measure by a few heavily advertised, high-priced medications, a nonpartisan study released yesterday found.”

Advertisements
h1

11222418

March 28, 2002

If Bioinformatics Is On the Ropes, Why Is UCSC’s David Haussler Smiling?
“I’m excited about the bioinformatics from the commercial point of view…”

h1

11217023

March 28, 2002

Bioscience Booming
“Spending in Connecticut’s bioscience sector grew 18 percent in 2001, bucking a recession and infusing the state’s economy with $560 million more than it did the previous year, a new report shows.”

h1

11212617

March 28, 2002

Unlocking the value in Big Pharma
“Although no guarantee of success, size is becoming more and more beneficial in several areas, including the costly process of discovering drugs.”

h1

11210364

March 28, 2002

Putting the Tech in Biotech
“We are going through a massive, massive process of amalgamation, moving from the individual discovery into the data management mode,” explains Dr Bruce Cornell, Chief Scientist, at ASX listed biotech device manufacturer Ambri.

h1

11175682

March 27, 2002

PPL to sell stem cell stake
“While historically we were spreading our resources across early-stage research, we’re now fairly and squarely behind our late-stage protein work.”

h1

11143582

March 26, 2002

Do gene patents wrap research in red tape?
“Taking a position that seems to question biotech’s financial underpinnings, Affymetrix Corp. last week told a government panel that gene patents are hindering medical progress and that the United States should quit handing them out.”